|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0023981,
umls-concept:C0034656,
umls-concept:C0083701,
umls-concept:C0087111,
umls-concept:C0138667,
umls-concept:C0521115,
umls-concept:C0681867,
umls-concept:C0878773,
umls-concept:C1457887,
umls-concept:C1704272,
umls-concept:C2328796
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-9-4
|
|
pubmed:abstractText |
To assess the efficacy and safety of propiverine hydrochloride (antimuscarinic), naftopidil (alpha(1)-adrenoceptor antagonist) or both in patients with male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia and concomitant overactive bladder (OAB).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1651-2065
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
307-14
|
|
pubmed:meshHeading |
pubmed-meshheading:19396723-Adrenergic alpha-Antagonists,
pubmed-meshheading:19396723-Aged,
pubmed-meshheading:19396723-Benzilates,
pubmed-meshheading:19396723-Dose-Response Relationship, Drug,
pubmed-meshheading:19396723-Drug Therapy, Combination,
pubmed-meshheading:19396723-Humans,
pubmed-meshheading:19396723-Male,
pubmed-meshheading:19396723-Middle Aged,
pubmed-meshheading:19396723-Muscarinic Antagonists,
pubmed-meshheading:19396723-Naphthalenes,
pubmed-meshheading:19396723-Piperazines,
pubmed-meshheading:19396723-Prospective Studies,
pubmed-meshheading:19396723-Prostatic Hyperplasia,
pubmed-meshheading:19396723-Treatment Outcome,
pubmed-meshheading:19396723-Urinary Bladder, Overactive,
pubmed-meshheading:19396723-Urination,
pubmed-meshheading:19396723-Urologic Diseases
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
|
|
pubmed:affiliation |
Department of Urology, Kawasaki Medical School, Kurashiki, Japan. uroyoko@med.kawasaki-m.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
